The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study.

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

The demand for weight-loss drugs like Ozempic and Zepbound is higher than ever, so much so that drugmakers Novo Nordisk and Eli Lilly are planning huge expansions in central North Carolina to meet the ...

A possible workaround came from a team led by Ernie Blevins of the University of Washington. They gave obese rats a low dose ...

By tweaking just two amino acids in the diet, researchers found a way to mimic the fat-burning effects of cold exposure. Shivering in the cold is hardly enjoyable, yet for some people, it carries an a ...

Russell Crowe's beautiful mind is focused on his health. The Oscar winner said he dropped from 126 kg (277 lbs.) to 100.9 kg (222 lbs.) since wrapping filming on the historical drama Nuremberg over a ...

During an announcement about lowering prices for weight-loss medications, Donald Trump referenced his communications director, Steve Cheung, saying he takes Ozempic. The comment came as Trump promoted ...